DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Mulder P, Morrison MC, Verschuren L. , et al.
Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.
Sci Rep 2016;
6 (01) 31542
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.